0001171843-17-005277.txt : 20170828 0001171843-17-005277.hdr.sgml : 20170828 20170828205452 ACCESSION NUMBER: 0001171843-17-005277 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170824 FILED AS OF DATE: 20170828 DATE AS OF CHANGE: 20170828 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDENBERG DAVID M CENTRAL INDEX KEY: 0001029578 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12104 FILM NUMBER: 171055937 MAIL ADDRESS: STREET 1: UBS GLOBAL ASSET MANAGEMENT (US) INC. STREET 2: 51 WEST 52ND STREET CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOMEDICS INC CENTRAL INDEX KEY: 0000722830 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 611009366 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 300 AMERICAN RD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 BUSINESS PHONE: 9736058200 MAIL ADDRESS: STREET 1: 300 AMERICAN ROAD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 4 1 formfour.xml FORM 4 X0306 4 2017-08-24 0 0000722830 IMMUNOMEDICS INC IMMU 0001029578 GOLDENBERG DAVID M C/O IMMUNOMEDICS, INC 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950 1 1 0 0 See Remarks Common Stock 2410489 D Common Stock 2017-08-24 4 S 0 25000 10.2442 D 3430578 I See Footnote Common Stock 2017-08-28 4 S 0 5000 11.45 D 3425578 I See Footnote Common Stock 2017-08-28 4 S 0 10000 11.5591 D 3415578 I See Footnote Includes a total of 635,935 shares held as joint tenants by the reporting person and his spouse, Ms. Cynthia L. Goldenberg, also known as Cynthia L. Sullivan, a director of the Company. The price in column 4 is a weighted average price. The prices actually received in this transaction range from $10.15 to $10.31. The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported. Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interests therein. The price in column 4 is a weighted average price. The prices actually received in this transaction range from $11.55 to $11.59. Chief Scientific Officer and Chief Patent Officer /s/ Cynthia L. Sullivan, Attorney-In-Fact 2017-08-28